Filana Therapeutics, Inc.
FLNA
$0.97
-$0.03-2.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 65.67% | -7.02% | -273.73% | -500.27% | -701.24% |
| Total Depreciation and Amortization | 2.93% | -7.88% | -17.31% | -32.49% | -29.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.32% | 140.09% | 121.31% | 120.89% | 121.12% |
| Change in Net Operating Assets | -202.21% | 235.15% | 2,191.02% | -95.64% | -81.38% |
| Cash from Operations | 70.05% | 72.70% | 72.42% | -7.42% | -11.17% |
| Capital Expenditure | -713.51% | -464.08% | -464.08% | -57.47% | 19.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -713.51% | -464.08% | -464.08% | -57.47% | 19.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | -99.93% | -99.19% | -99.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -139.29% | -100.37% | -100.19% | -99.19% | -99.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.71% | -349.57% | -544.64% | -277.79% | -344.28% |